This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Infectious Diseases. This report contains market size and forecasts of mRNA Vaccines for Infectious Diseases in global, including the following market information:
Global mRNA Vaccines for Infectious Diseases Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global mRNA Vaccines for Infectious Diseases market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Infectious Disease Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of mRNA Vaccines for Infectious Diseases include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the mRNA Vaccines for Infectious Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines for Infectious Diseases Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Type, 2022 (%)
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines for Infectious Diseases Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Cancer
Global mRNA Vaccines for Infectious Diseases Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Vaccines for Infectious Diseases revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies mRNA Vaccines for Infectious Diseases revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines for Infectious Diseases, market overview.
Chapter 2: Global mRNA Vaccines for Infectious Diseases market size in revenue.
Chapter 3: Detailed analysis of mRNA Vaccines for Infectious Diseases company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Vaccines for Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines for Infectious Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines for Infectious Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines for Infectious Diseases Overall Market Size
2.1 Global mRNA Vaccines for Infectious Diseases Market Size: 2022 VS 2032
2.2 Global mRNA Vaccines for Infectious Diseases Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Vaccines for Infectious Diseases Players in Global Market
3.2 Top Global mRNA Vaccines for Infectious Diseases Companies Ranked by Revenue
3.3 Global mRNA Vaccines for Infectious Diseases Revenue by Companies
3.4 Top 3 and Top 5 mRNA Vaccines for Infectious Diseases Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Vaccines for Infectious Diseases Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Vaccines for Infectious Diseases Players in Global Market
3.6.1 List of Global Tier 1 mRNA Vaccines for Infectious Diseases Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Vaccines for Infectious Diseases Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines for Infectious Diseases Market Size Markets, 2022 & 2032
4.1.2 Infectious Disease Vaccines
4.1.3 Cancer Vaccines
4.2 By Type - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
4.2.3 By Type - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines for Infectious Diseases Market Size, 2022 & 2032
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
5.2.3 By Application - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global mRNA Vaccines for Infectious Diseases Market Size, 2022 & 2032
6.2 By Region - Global mRNA Vaccines for Infectious Diseases Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccines for Infectious Diseases Revenue, 2024-2032
6.2.3 By Region - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.3.2 US mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.3.3 Canada mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.3.4 Mexico mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.4.2 Germany mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.3 France mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.4 U.K. mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.5 Italy mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.6 Russia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.7 Nordic Countries mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.4.8 Benelux mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.5.2 China mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.3 Japan mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.4 South Korea mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.5 Southeast Asia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.5.6 India mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.6.2 Brazil mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.6.3 Argentina mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Vaccines for Infectious Diseases Revenue, 2018-2032
6.7.2 Turkey mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.3 Israel mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.4 Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
6.7.5 UAE mRNA Vaccines for Infectious Diseases Market Size, 2018-2032
7 mRNA Vaccines for Infectious Diseases Companies Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.1.5 Moderna Therapeutics Key News & Latest Developments
7.2 CureVac
7.2.1 CureVac Company Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines for Infectious Diseases Major Product Offerings
7.2.4 CureVac mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.2.5 CureVac Key News & Latest Developments
7.3 Translate Bio
7.3.1 Translate Bio Company Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Major Product Offerings
7.3.4 Translate Bio mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.3.5 Translate Bio Key News & Latest Developments
7.4 BioNTech
7.4.1 BioNTech Company Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines for Infectious Diseases Major Product Offerings
7.4.4 BioNTech mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.4.5 BioNTech Key News & Latest Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.5.5 Sangamo Therapeutics Key News & Latest Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Major Product Offerings
7.6.4 Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.6.5 Argos Therapeutics Key News & Latest Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Major Product Offerings
7.7.4 In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.7.5 In-Cell-Art Key News & Latest Developments
7.8 eTheRNA
7.8.1 eTheRNA Company Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Major Product Offerings
7.8.4 eTheRNA mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.8.5 eTheRNA Key News & Latest Developments
7.9 Ethris
7.9.1 Ethris Company Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines for Infectious Diseases Major Product Offerings
7.9.4 Ethris mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.9.5 Ethris Key News & Latest Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue in Global Market (2018-2023)
7.10.5 Tiba Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. mRNA Vaccines for Infectious Diseases Market Opportunities & Trends in Global Market
Table 2. mRNA Vaccines for Infectious Diseases Market Drivers in Global Market
Table 3. mRNA Vaccines for Infectious Diseases Market Restraints in Global Market
Table 4. Key Players of mRNA Vaccines for Infectious Diseases in Global Market
Table 5. Top mRNA Vaccines for Infectious Diseases Players in Global Market, Ranking by Revenue (2022)
Table 6. Global mRNA Vaccines for Infectious Diseases Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global mRNA Vaccines for Infectious Diseases Revenue Share by Companies, 2018-2023
Table 8. Global Companies mRNA Vaccines for Infectious Diseases Product Type
Table 9. List of Global Tier 1 mRNA Vaccines for Infectious Diseases Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccines for Infectious Diseases Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - mRNA Vaccines for Infectious Diseases Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - mRNA Vaccines for Infectious Diseases Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - mRNA Vaccines for Infectious Diseases Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - mRNA Vaccines for Infectious Diseases Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global mRNA Vaccines for Infectious Diseases Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global mRNA Vaccines for Infectious Diseases Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2024-2032
Table 30. Moderna Therapeutics Company Summary
Table 31. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Offerings
Table 32. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 33. Moderna Therapeutics Key News & Latest Developments
Table 34. CureVac Company Summary
Table 35. CureVac mRNA Vaccines for Infectious Diseases Product Offerings
Table 36. CureVac mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 37. CureVac Key News & Latest Developments
Table 38. Translate Bio Company Summary
Table 39. Translate Bio mRNA Vaccines for Infectious Diseases Product Offerings
Table 40. Translate Bio mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 41. Translate Bio Key News & Latest Developments
Table 42. BioNTech Company Summary
Table 43. BioNTech mRNA Vaccines for Infectious Diseases Product Offerings
Table 44. BioNTech mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 45. BioNTech Key News & Latest Developments
Table 46. Sangamo Therapeutics Company Summary
Table 47. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Offerings
Table 48. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 49. Sangamo Therapeutics Key News & Latest Developments
Table 50. Argos Therapeutics Company Summary
Table 51. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Offerings
Table 52. Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 53. Argos Therapeutics Key News & Latest Developments
Table 54. In-Cell-Art Company Summary
Table 55. In-Cell-Art mRNA Vaccines for Infectious Diseases Product Offerings
Table 56. In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 57. In-Cell-Art Key News & Latest Developments
Table 58. eTheRNA Company Summary
Table 59. eTheRNA mRNA Vaccines for Infectious Diseases Product Offerings
Table 60. eTheRNA mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 61. eTheRNA Key News & Latest Developments
Table 62. Ethris Company Summary
Table 63. Ethris mRNA Vaccines for Infectious Diseases Product Offerings
Table 64. Ethris mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 65. Ethris Key News & Latest Developments
Table 66. Tiba Biotechnology Company Summary
Table 67. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Offerings
Table 68. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue (US$, Mn) & (2018-2023)
Table 69. Tiba Biotechnology Key News & Latest Developments
List of Figures
Figure 1. mRNA Vaccines for Infectious Diseases Segment by Type in 2022
Figure 2. mRNA Vaccines for Infectious Diseases Segment by Application in 2022
Figure 3. Global mRNA Vaccines for Infectious Diseases Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines for Infectious Diseases Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global mRNA Vaccines for Infectious Diseases Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Vaccines for Infectious Diseases Revenue in 2022
Figure 8. By Type - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 9. By Application - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 10. By Type - Global mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 12. By Application - Global mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 14. By Region - Global mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 15. By Country - North America mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 16. US mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 17. Canada mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 20. Germany mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 21. France mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 23. Italy mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 24. Russia mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 28. China mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 29. Japan mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 32. India mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 34. Brazil mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa mRNA Vaccines for Infectious Diseases Revenue Market Share, 2018-2032
Figure 37. Turkey mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 38. Israel mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 40. UAE mRNA Vaccines for Infectious Diseases Revenue, (US$, Mn), 2018-2032
Figure 41. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CureVac mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Translate Bio mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BioNTech mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Argos Therapeutics mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. In-Cell-Art mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. eTheRNA mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ethris mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
